← Back to Clinical Trials
Recruiting NCT06201403

NCT06201403 Mechanical Properties of Peripheral and Accessory Respiratory Muscles in Chronic Obstructive Pulmonary Disease Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06201403
Status Recruiting
Phase —
Sponsor Istanbul Medipol University Hospital
Condition COPD
Study Type OBSERVATIONAL
Enrollment 66 participants
Start Date 2024-01-20
Primary Completion 2026-01-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 75 Years
Study Type OBSERVATIONAL
Interventions
Determination of biomechanical properties of muscles

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 66 participants in total. It began in 2024-01-20 with a primary completion date of 2026-01-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The biomechanical properties of accessory respiratory muscles and peripheral muscles of COPD and healthy subjects will be measured and compared with the MyotonPro device.

Eligibility Criteria

Inclusion Criteria: * Being diagnosed with group C and D COPD according to GOLD staging * Having been using the same medications for the last 4 weeks * No additional comorbid diseases of the orthopedic, neurological or cardiac system Exclusion Criteria: * Presence of another respiratory system disease other than COPD * Patients who have had an acute COPD exacerbation in the last 4 weeks * Patients experiencing COPD exacerbations during the study protocol * Presence of fatty tissue at the measurement points, which may impair the measurement quality. * Have already participated in another clinical trial within the last 30 days that may affect the results of the study. Inclusion Criteria for Healthy Cases * Being over 18 years of age * Not having any diagnosed chronic disease * Not being a smoker

Contact & Investigator

Central Contact

ESRA PEHLİVAN

✉ fztesrakambur@yahoo.com

📞 09050585279

Frequently Asked Questions

Who can join the NCT06201403 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying COPD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06201403 currently recruiting?

Yes, NCT06201403 is actively recruiting participants. Contact the research team at fztesrakambur@yahoo.com for enrollment information.

Where is the NCT06201403 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT06201403 clinical trial?

NCT06201403 is sponsored by Istanbul Medipol University Hospital. The trial plans to enroll 66 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology